VivoSim Labs, Inc. ( VIVS) - Key Metrics
VIVS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0 | -$0.26 | -$0.61 | -$0.62 |
| 2026Q4 | $0.02 | -$2.23 | -$0.86 | -$0.86 |
| 2026Q3 | $0.02 | -$1.84 | -$1.55 | -$1.55 |
| 2026Q2 | $0.02 | -$1.74 | -$1.62 | -$1.62 |
| 2026Q1 | $0.03 | -$1.94 | -$2.69 | -$2.69 |
VIVS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -1.07 |
| 2026Q4 | 0% | -0.16 |
| 2026Q3 | 0% | -0.25 |
| 2026Q2 | 0% | -0.42 |
| 2026Q1 | 0% | -0.19 |
VIVS
Price: $0.29
52 week price:
Earnings Per Share: -5.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.1 million